MedPath

Glycopyrrolate

Glycopyrrolate Tablets, USP 1 mg and Glycopyrrolate Tablets, USP 2 mg

Approved
Approval ID

bfccdb26-5047-4b54-9732-ffac2d78e4d1

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 21, 2023

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Glycopyrrolate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71335-2075
Application NumberANDA207201
Product Classification
M
Marketing Category
C73584
G
Generic Name
Glycopyrrolate
Product Specifications
Route of AdministrationORAL
Effective DateMarch 10, 2022
FDA Product Classification

INGREDIENTS (6)

GLYCOPYRROLATEActive
Quantity: 1 mg in 1 1
Code: V92SO9WP2I
Classification: ACTIB
LACTOSE, UNSPECIFIED FORMInactive
Code: J2B2A4N98G
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
DIBASIC CALCIUM PHOSPHATE DIHYDRATEInactive
Code: O7TSZ97GEP
Classification: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Glycopyrrolate - FDA Drug Approval Details